Latest News - Acne

Friday, February 03, 2017 | Acquisitions and Mergers, PracticalDermatology.com, PracticalDermatology.com, Suneva, ZO Skin Heath

Breaking Business News: ZO Skin Health, Inc. Acquires Refissa from Suneva Medical

ZO Skin Health, Inc. has acquired the worldwide rights to ReFissa as well as its generic equivalent tretinoin from Suneva Medical. Financial terms for the acquisition were not disclosed. ReFissa is…

Read the full story

Thursday, February 02, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, Galderma

Galderma’s OTC Differin Gel Hits Store Shelves

Galderma’s Differin Gel 0.1% (adapalene) is now available over the counter (OTC) at major retail and drug stores. Galderma officially launched the gel at a New York City media fete, and …

Read the full story

Friday, January 27, 2017 | Personnel/Company News, Phase 3/4 Trials, PracticalDermatology.com, Research and Publications, Novan

Topline Results from Novan's SB204 Phase 3 Pivotal Trials: Inconsistent Across Trials

Novan, Inc. (NASDAQ:NOVN) today announced  top-line results from the Company’s two, replicate Phase 3 pivotal clinical trials for SB204 in the treatment of acne vulgaris. In the intent-to-t…

Read the full story

Tuesday, January 24, 2017 | PracticalDermatology.com, Sun Pharmaceutical Industries Ltd

Sun Pharma Introduces Leave Acne Behind Patient Initiative

Sun Pharma introudced a new initiative -- “Leave Acne Behind™" -- to educate patients and create awareness of severe recalcitrant nodular acne (SRNA). Sun Pharma reports that out o…

Read the full story

Monday, January 23, 2017 | Personnel/Company News, PracticalDermatology.com, BioPharmX Corporation, BioPharmX Corporation

Specialty Pharma Industry Vet Charles Gregory Vontz Joins BioPharmX Board of Directors

Charles "Greg" Vontz  is joining rhe Board of Directors of BioPharmX Corporation as an independent director, effective as of Jan. 17.  Vontz's appointment expands the board …

Read the full story

Wednesday, January 18, 2017 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com

First Patient Treated in Dermata Therapeutics Phase 2 Acne Rosacea Clinical Study

The first patient has been dosed in Dermata Therapeutics’s Phase 2 acne rosacea study of DMT210, a topical gel specifically developed to downregulate the proinflammatory cytokines in the skin re…

Read the full story

Friday, January 13, 2017 | PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates

Actress Bella Thorne Helps Bioré Launch Three New Acne Products

Actress Bella Thorne is the new face of Bioré® Skincare’s trio of acne-fighting charcoal and baking soda products, which are set to launch in early 2017. The new collection include…

Read the full story

Wednesday, January 04, 2017 | PracticalDermatology.com, Product Launches and Updates, Research and Publications, BioPharmX Corporation, BioPharmX Corporation

Enrollment Complete in BioPharmX's Phase 2b Study of Topical Minocycline Gel for Acne

BioPharmX Corporation completed enrollment in the OPAL (tOPicAL Minocycline Gel) study, a Phase 2b dose finding clinical trial to assess the efficacy and safety of BPX-01 for the treatment of acne vul…

Read the full story

Wednesday, January 04, 2017 | PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, PracticalDermatology.com, Research and Publications

Study Examines Diversity in Dermatologic Clinical Trials

Dermatologic clinical trials within the United States reflect the growing diversity of the US population, but reporting of both sex and racial/ethnic diversity of research cohorts is still lacking, es…

Read the full story

Tuesday, December 27, 2016 | Personnel/Company News, PracticalDermatology.com, PracticalDermatology.com, Product Launches and Updates, La Roche-Posay

La Roche-Posay Nabs 20 Beauty Awards in 2016

La Roche-Posay (LRP) won 20 beauty awards, almost doubling its wins from the previous year, the company has announced. The awards, judged by editors, industry leaders and elite experts who test thousa…

Read the full story

Friday, December 09, 2016 | PracticalDermatology.com, Product Launches and Updates, PuraCap

PuraCap Rolls Out Two New Acne Products

PuraCap Pharmaceutical LLC is rolling out two new acne products, Eptex Controlled Release Acne Wash and Eptex Controlled Release Acne Relief Lotion.  Available through healthcare professionals…

Read the full story

Monday, November 28, 2016 | Personnel/Company News, Phase 3/4 Trials, PracticalDermatology.com, Research and Publications

Patient Enrollment Complete in Phase 3 Acne Trials for Minocycline Foam FMX101

Patient enrollment is now complete for two Phase 3 clinical trials evaluating the efficacy and safety of FMX101, a topical 4 percent minocycline foam for the treatment of moderate-to-severe acne, acco…

Read the full story

Friday, November 18, 2016 | PracticalDermatology.com, Research and Publications, American Academy of Dermatology

Office Job, Stress And Diet May Increase Risk of Adult Acne

Lifestyle factors -- including stress -- may play a role in adult acne development, a new study suggests. Researchers in Italy compared 248 women diagnosed with adult acne to 270 women without…

Read the full story

Thursday, November 10, 2016 | PracticalDermatology.com, Research and Publications, BioPharmX Corporation

Two New Studies Suggest BPX-01 Topical Minocycline May Hold Advantages

Taken together, two new studies suggest that BioPharmX Corp.’s BPX-01 topical minocycline may have a favorable pharmacokinetic advantage compared with oral minocycline for the treatment of acne …

Read the full story

Wednesday, October 19, 2016 | Personnel/Company News, PracticalDermatology.com, Research and Publications, Novan

Novan: Phase 2b Data for SB204 Gel to be Presented at Fall Clinical Dermatology Conference

Results from Novan’s Phase 2b clinical trial to evaluate the efficacy and safety of topical nitric oxide-releasing product candidate SB204 gel for the treatment of acne vulgaris will be presente…

Read the full story
Load More